Veltuzumab
- Generic Name
- Veltuzumab
- Drug Type
- Biotech
- CAS Number
- 728917-18-8
- Unique Ingredient Identifier
- BPD4DGQ314
Overview
Veltuzumab is a monoclonal antibody which, as of October 2009, is undergoing Phase I/II clinical trials for the treatment of non-Hodgkin's lymphoma.
Background
Veltuzumab is a monoclonal antibody which, as of October 2009, is undergoing Phase I/II clinical trials for the treatment of non-Hodgkin's lymphoma.
Indication
Investigated for use/treatment in lymphoma (non-hodgkin's).
Associated Conditions
No associated conditions information available.
Clinical Trials
FDA Approved Products
No FDA products found for this drug
Singapore Approved Products
No Singapore products found for this drug
Drug Development Updates
Stay informed with timely notifications on clinical trials and research advancements.
© Copyright 2025. All Rights Reserved by MedPath